New York State Teachers Retirement System Decreases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

New York State Teachers Retirement System reduced its holdings in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) by 15.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 76,314 shares of the company’s stock after selling 14,140 shares during the quarter. New York State Teachers Retirement System owned 0.14% of Azenta worth $4,971,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of AZTA. TFC Financial Management Inc. purchased a new stake in Azenta during the third quarter worth approximately $25,000. Headlands Technologies LLC purchased a new stake in Azenta during the third quarter worth approximately $33,000. State of Wyoming grew its stake in Azenta by 29.5% during the second quarter. State of Wyoming now owns 1,392 shares of the company’s stock worth $65,000 after buying an additional 317 shares during the period. Neo Ivy Capital Management purchased a new stake in Azenta during the third quarter worth approximately $73,000. Finally, Covestor Ltd grew its stake in Azenta by 17.5% during the third quarter. Covestor Ltd now owns 1,714 shares of the company’s stock worth $86,000 after buying an additional 255 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Trading Down 2.9 %

NASDAQ AZTA opened at $54.75 on Friday. Azenta, Inc. has a 52 week low of $36.01 and a 52 week high of $69.16. The stock has a market cap of $3.05 billion, a price-to-earnings ratio of -176.61 and a beta of 1.53. The company has a 50-day moving average price of $62.05 and a two-hundred day moving average price of $58.90.

Azenta (NASDAQ:AZTAGet Free Report) last posted its earnings results on Wednesday, February 7th. The company reported $0.02 EPS for the quarter. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The firm had revenue of $154.32 million during the quarter, compared to analysts’ expectations of $151.86 million. As a group, equities research analysts expect that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. B. Riley upped their target price on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research note on Thursday, February 1st. Evercore ISI dropped their target price on Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a research report on Thursday, April 4th. Jefferies Financial Group initiated coverage on shares of Azenta in a report on Thursday, April 4th. They set a “hold” rating and a $64.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price objective on shares of Azenta in a report on Monday, April 8th. Finally, Stephens reiterated an “equal weight” rating and issued a $70.00 price objective on shares of Azenta in a research report on Thursday, February 8th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Azenta presently has a consensus rating of “Hold” and an average price target of $69.60.

Get Our Latest Report on Azenta

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Read More

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.